Umang Vohra's guest appearances

Umang Vohra

The Mittal Institute, Harvard University

The Medicine Box

Curve Benders by David Nour

Dorie Clark

Michael Bungay Stanier

David Burkus

Rahul Mehrotra

Marc Lore

Charlene Li

Alan Weiss

Peter Bregman

Liz Wiseman

Amy Edmondson

Margaret Heffernan

Caroline Webb

Bruce Tulgan

Morgan Stanley

Mitch Joel

OwlTail

Pharma industry’s Robinhood, Cipla is looking to increase its presence in the US market, the company’s MD and Global CEO Umang Vohra.  In this edition of The Medicine Box Podcast, CNBC-TV18’s Ekta Batra talks to Vohra about Cipla’s plan to capture a larger share of the US market, the firm’s COVID-19 portfolio – from Tocilizumab to Remdesivir to Favipiravir, new products, growth outlook and more.  Cipla, which is India’s third largest pharma company and is present in more than 80 countries with over 46 manufacturing facilities, is looking to manufacture complex drugs and injectables in respiratory and cancer segments, Vohra said.  Tune in to The Medicine Box Podcast for more 

Pharma industry’s Robinhood, Cipla is looking to increase its presence in the US market, the company’s MD and Global CEO Umang Vohra. In this edition of The Medicine Box Podcast, CNBC-TV18’s Ekta Batra talks to Vohra about Cipla’s plan to capture a larger share of the US market, the firm’s COVID-19 portfolio – from Tocilizumab to Remdesivir to Favipiravir, new products, growth outlook and more. Cipla, which is India’s third largest pharma company and is present in more than 80 countries with over 46 manufacturing facilities, is looking to manufacture complex drugs and injectables in respiratory and cancer segments, Vohra said. Tune in to The Medicine Box Podcast for more

39: The Medicine Box: Cipla’s Umang Vohra on COVID-19 portfolio, upcoming drugs, US business outlook and more

He has been Managing Director and Global Chief Executive Officer of Cipla since September 2016. Previously, he was Cipla's Global Chief Financial Officer and Global Chief Operating Officer. Prior to joining Cipla, he led the North American business of Dr. Reddy’s Laboratories. After gaining degrees in engineering, marketing, and finance, he led teams at Eicher Motors and PepsiCo. Under his leadership, Cipla has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Cipla Management Council, his vision is to define and execute Cipla’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organization. Recognized as an action-oriented industry leader, he is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics, and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients. Join me on this episode of the Curve Benders podcast with Cipla's global CEO, Umang Vohra. Read the excerpt from my journey in writing the Curve Benders book, and an article about this interview, in our private, free, online community, Nour Forum. Learn more at NourGroup.com/Forum--- Send in a voice message: https://podcasters.spotify.com/pod/show/david-nour/message

He has been Managing Director and Global Chief Executive Officer of Cipla since September 2016. Previously, he was Cipla's Global Chief Financial Officer and Global Chief Operating Officer. Prior to joining Cipla, he led the North American business of Dr. Reddy’s Laboratories. After gaining degrees in engineering, marketing, and finance, he led teams at Eicher Motors and PepsiCo. Under his leadership, Cipla has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Cipla Management Council, his vision is to define and execute Cipla’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organization. Recognized as an action-oriented industry leader, he is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics, and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients. Join me on this episode of the Curve Benders podcast with <a href="https://www.cipla.com/" rel="nofollow" target="_blank">Cipla's</a> global CEO, Umang Vohra. Read the excerpt from my journey in writing the Curve Benders book, and an article about this interview, in our private, free, online community, Nour Forum. Learn more at <a href="https://www.nourgroup.com/forum" rel="nofollow" target="_blank">NourGroup.com/Forum</a>--- Send in a voice message: <a href="https://podcasters.spotify.com/pod/show/david-nour/message" rel="nofollow" target="_blank">https://podcasters.spotify.com/pod/show/david-nour/message</a>

32 - From Illness to Wellness with Umang Vohra, Global CEO - Cipla

In this clip from our "Science, Business, and Vaccine Development to Combat the Pandemic" podcast, Umang Vohra — Managing Director and Global Chief Executive Officer of Cipla Ltd — discusses the balance between equitable access and vaccine nationalism, as well as the availability and affordability of the vaccine, with a focus on South Asia.

Umang Vohra: Availability and Affordability of a Vaccine